Unknown

Dataset Information

A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K.


ABSTRACT:

Background and purpose

Cathepsin K (CatK) is a major drug target for the treatment of osteoporosis. Potent active site-directed inhibitors have been developed and showed variable success in clinical trials. These inhibitors block the entire activity of CatK and thus may interfere with other pathways. The present study investigates the antiresorptive effect of an exosite inhibitor that selectively inhibits only the therapeutically relevant collagenase activity of CatK.

Experimental approach

Human osteoclasts and fibroblasts were used to analyse the effect of the exosite inhibitor, ortho-dihydrotanshinone (DHT1), and the active site inhibitor, odanacatib (ODN), on bone resorption and TGF-ß1 degradation. Cell cultures, Western blot, light and scanning electron microscopy as wel

SUBMITTER: Panwar P 

PROVIDER: S-EPMC5341232 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature